Evidence map›Paper›PMID 41841531›Full record

ReviewNano letters2026

Industrial Adoption of Carbon Nanotubes.

Dana Goerzen, Matteo Pasquali, Mijin Kim, Daniel A Heller

Abstract readReview
In one paragraph

Review in Nano letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dana GoerzenMemorial Sloan Kettering Cancer Center, New York, New York 10065, United States.ORCID 0000-0001-9645-3503
Matteo PasqualiDepartment of Chemical and Biomolecular Engineering, Department of Materials Science and NanoEngineering, The Carbon Hub, Rice University, Houston, Texas 77005, United States.ORCID 0000-0001-5951-395X
Mijin KimDepartment of Chemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0000-0002-7781-9466
Daniel A HellerMemorial Sloan Kettering Cancer Center, New York, New York 10065, United States.ORCID 0000-0002-6866-0000

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Machine Perception Nanosensor Array Platform to Capture Whole Disease Fingerprints of Early Stage Pancreatic CancerR00EB033580 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI Mijin Kim · 2024 to 2026
$692k
NCI NIH HHS P30 CA008748NIBIB NIH HHS R00 EB033580
6 · The paper itself

Abstract

Over the past 30 years, carbon nanotubes have emerged as one of the most exciting classes of nanomaterials due to their unique physicochemical properties. While challenges in nanotube synthesis and processing initially hindered their adoption, many of these barriers have since been addressed by research and manufacturing advances, resulting in substantial industrial application of nanotubes across multiple sectors. However, much of this progress is not known in the academic community. This perspective discusses the current landscape and outlook of industrial integration of carbon nanotubes and key factors mediating widespread integration across all major material-related areas of human activity.

Indexed as

IndustryNanotechnologyNanotubes, CarbonHumansNanotubes, Carbonbatteriescarbon nanotubescompositesindustrymaterialssensors

Identifiers

PMID41841531
PMCPMC13047723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.